S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: Wall Street subdued as it inches toward bull market
The $193 Billion US-China War You Don't Know About (Ad)
Tesla: How and Why It Gets To $300
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
It Is Not Too Late To “Git” On Board With GitLab 
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: Wall Street subdued as it inches toward bull market
The $193 Billion US-China War You Don't Know About (Ad)
Tesla: How and Why It Gets To $300
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
It Is Not Too Late To “Git” On Board With GitLab 
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: Wall Street subdued as it inches toward bull market
The $193 Billion US-China War You Don't Know About (Ad)
Tesla: How and Why It Gets To $300
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
It Is Not Too Late To “Git” On Board With GitLab 
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: Wall Street subdued as it inches toward bull market
The $193 Billion US-China War You Don't Know About (Ad)
Tesla: How and Why It Gets To $300
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
It Is Not Too Late To “Git” On Board With GitLab 
OTCMKTS:MBGNF

Many Bright Ideas Technologies (MBGNF) Competitors

$0.11
0.00 (0.00%)
(As of 05/12/2023)
Compare
Today's Range
$0.11
$0.11
50-Day Range
$0.11
$0.11
52-Week Range
$0.04
$1.00
Volume
N/A
Average Volume
4,936 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MBGNF vs. BIAFW, EPGNY, ETAH, IMEXF, MEDD, PRLX, SMMNY, STRRP, VIMGF, and WUXIF

Should you be buying Many Bright Ideas Technologies stock or one of its competitors? The main competitors of Many Bright Ideas Technologies include bioAffinity Technologies (BIAFW), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Imagin Medical (IMEXF), Medical Imaging (MEDD), Parallax Health Sciences (PRLX), Siemens Healthineers (SMMNY), Star Equity (STRRP), Vimian Group AB (publ) (VIMGF), and WuXi AppTec (WUXIF). These companies are all part of the "diagnostics & research" industry.

Many Bright Ideas Technologies vs.

bioAffinity Technologies (NASDAQ:BIAFW) and Many Bright Ideas Technologies (OTCMKTS:MBGNF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies N/A N/A N/A
Many Bright Ideas Technologies N/A N/A N/A

In the previous week, Many Bright Ideas Technologies had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Many Bright Ideas Technologies and 0 mentions for bioAffinity Technologies. Many Bright Ideas Technologies' average media sentiment score of 1.57 beat bioAffinity Technologies' score of 0.00 indicating that Many Bright Ideas Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Neutral
Many Bright Ideas Technologies Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.72 thousandN/AN/AN/AN/A
Many Bright Ideas TechnologiesN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Many Bright Ideas Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Many Bright Ideas Technologies received 29 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
bioAffinity TechnologiesN/AN/A
Many Bright Ideas TechnologiesOutperform Votes
29
69.05%
Underperform Votes
13
30.95%

Summary

Many Bright Ideas Technologies beats bioAffinity Technologies on 3 of the 4 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBGNF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBGNF vs. The Competition

MetricMany Bright Ideas TechnologiesDiagnostics & Research IndustryMedical SectorOTCMKTS Exchange
Market CapN/A$3.35B$4.57B$7.84B
Dividend YieldN/A5.15%5.93%18.53%
P/E RatioN/A6.0286.918.46
Price / SalesN/A3,021.313,437.13128.60
Price / CashN/A13.1390.9020.93
Price / BookN/A9.954.704.02
Net IncomeN/A$101.75M$117.19M$714.51M
7 Day PerformanceN/A0.62%4.56%1.50%
1 Month PerformanceN/A-10.22%2.60%0.08%
1 Year PerformanceN/A-36.92%12.27%-4.83%

Many Bright Ideas Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAFW
bioAffinity Technologies
0 of 5 stars
$0.29
+11.5%
N/AN/A$0.00$5,724.000.00N/APositive News
Gap Down
EPGNY
Epigenomics
0 of 5 stars
$2.39
flat
N/AN/A$0.00N/A-0.7832
ETAH
Eternity Healthcare
0 of 5 stars
N/AN/AN/A$0.00N/A0.001Gap Up
IMEXF
Imagin Medical
0 of 5 stars
C$0.06
-13.7%
N/A-53.0%C$0.00N/A0.00N/AGap Down
MEDD
Medical Imaging
0 of 5 stars
$0.00
flat
N/AN/A$0.00N/A-0.1221
PRLX
Parallax Health Sciences
0 of 5 stars
N/AN/AN/A$0.00N/A0.009Gap Up
SMMNY
Siemens Healthineers
0 of 5 stars
$28.61
-0.4%
$62.56
+118.7%
-3.7%$0.00N/A0.0066,800
STRRP
Star Equity
0 of 5 stars
$9.30
+0.4%
N/AN/A$0.00$112.81M0.00N/ANews Coverage
VIMGF
Vimian Group AB (publ)
0 of 5 stars
C$3.32
flat
N/AN/AC$0.00N/A0.00N/ANegative News
WUXIF
WuXi AppTec
0 of 5 stars
$8.69
flat
N/AN/A$0.00N/A0.0036,997

Related Companies and Tools

This page (OTCMKTS:MBGNF) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -